Literature DB >> 22303530

Clinical features of gout.

W Grassi1, R De Angelis.   

Abstract

Gout is a metabolic disease characterized by hyperuricemia and the deposition of monosodium urate (MSU) crystals in the joints and soft tissues, consisting of a self-limited acute phase characterized by recurrent attacks of synovitis and a chronic phase in which inflammatory and structural changes of the joints and periarticular tissues may lead to persistent symptoms. Acute gout is characterized by a sudden monoarthritis of rapid onset, with intense pain, mostly affecting the big toe (50% of initial attacks), the foot, ankle, midtarsal, knee, wrist, finger, and elbow. Acute flares also occur in periarticular structures, including bursae and tendons. The presence of characteristic MSU crystals in the joint fluid, appearing needle-like and showing strong negative birefringence by polarized microscopy, is pivotal to confirm the diagnosis of gout. The time interval separating the first attack from subsequent episodes of acute synovitis may be widely variable, ranging from a few days to several years. During the period between acute attacks the patient is asymptomatic even if MSU deposition may continue to increase silently. The factors that control the rate, location, and degree of ongoing deposition in gouty patients are not well defined. Chronic gout is the natural evolution of untreated hyperuricemia in patients with gouty attacks followed by pain-free intercritical periods. It is characterized by the deposition of solid MSU crystal aggregates in a variety of tissues including joints, bursae and tendons. Tophi can occur in a variety of locations including the helix of the ear, olecranon bursa, and over the interphalangeal joints. Their development is usually related with both the degree and the duration of hyperuricemia. About 20% of patients with gout have urinary tract stones and can develop an interstitial urate nephropathy. There is a strong association between hyperuricaemia and the metabolic syndrome (the constellation of insulin resistance, hypertension, obesity and dyslipidaemia), and gouty patients often have a medical history of kidney disease, diabetes mellitus and signs of vascular illness such as coronary artery disease, heart failure and stroke, resulting with a poor overall quality of life.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22303530     DOI: 10.4081/reumatismo.2011.238

Source DB:  PubMed          Journal:  Reumatismo        ISSN: 0048-7449


  15 in total

Review 1.  [Foot and ankle tumours : Part II: Malignant bone tumours and soft tissue tumours of the foot with differential diagnostic hints].

Authors:  T Grieser
Journal:  Radiologe       Date:  2018-05       Impact factor: 0.635

2.  Fingolimod Phosphate (FTY720-P) Activates Protein Phosphatase 2A in Human Monocytes and Inhibits Monosodium Urate Crystal-Induced Interleukin-1β Production.

Authors:  Marwa Qadri; Sandy ElSayed; Khaled A Elsaid
Journal:  J Pharmacol Exp Ther       Date:  2020-11-25       Impact factor: 4.030

Review 3.  Gout: An old disease in new perspective - A review.

Authors:  Gaafar Ragab; Mohsen Elshahaly; Thomas Bardin
Journal:  J Adv Res       Date:  2017-05-10       Impact factor: 10.479

4.  Gout of hand and wrist: the value of US as compared with DECT.

Authors:  Andrea S Klauser; Ethan J Halpern; Sylvia Strobl; Mohamed M H Abd Ellah; Johann Gruber; Rosa Bellmann-Weiler; Thomas Auer; Gudrun Feuchtner; Werner Jaschke
Journal:  Eur Radiol       Date:  2018-04-20       Impact factor: 5.315

5.  Nasal gouty tophus: Report a rare case presenting as a nasal hump with nasal obstruction.

Authors:  John Chung-Han Wu; Pang-Yun Chou; Chih-Hao Chen
Journal:  Biomed J       Date:  2016-09-20       Impact factor: 4.910

6.  Development of a multivariable improvement measure for gout.

Authors:  Naomi Schlesinger; N Lawrence Edwards; Anthony E Yeo; Peter E Lipsky
Journal:  Arthritis Res Ther       Date:  2020-06-29       Impact factor: 5.156

7.  Association of gout and colorectal cancer in Taiwan: a nationwide population-based cohort study.

Authors:  Jen-Pin Chuang; Jenq-Chang Lee; Tzeng-Horng Leu; Atik Choirul Hidajah; Ya-Hui Chang; Chung-Yi Li
Journal:  BMJ Open       Date:  2019-10-09       Impact factor: 2.692

Review 8.  A brief review on in vivo models for Gouty Arthritis.

Authors:  Tulsi Patil; Arun Soni; Sanjeev Acharya
Journal:  Metabol Open       Date:  2021-06-14

Review 9.  Urate Crystals; Beyond Joints.

Authors:  Muhammad Israr Ahmad; Salman Masood; Daniel Moreira Furlanetto; Savvas Nicolaou
Journal:  Front Med (Lausanne)       Date:  2021-06-04

Review 10.  The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update.

Authors:  Robert Eckenstaler; Ralf A Benndorf
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.